TABLE 11: Treatment - surgery

% of Cases treated with Surgery
Country average (population) Country average (country) England Scotland Wales1 Northern Ireland Republic of Ireland
All invasive xnmsc 48.7% 47.2% 49.6% 40.1% 48.1% 50.8%
All xnmsc 0-24 51.7% 52.4% 51.8% 47.8% 50.6% 59.5%
All xnmsc 25-59 66.1% 64.5% 66.8% 59.1% 68.0% 64.2%
All xnmsc 60-79 48.7% 46.5% 49.8% 39.2% 47.3% 49.7%
All xnmsc 80+ 30.1% 29.7% 30.8% 21.4% 31.2% 35.5%
Haematology 6.5% 7.7% 6.4% 5.8% 6.6% 11.9%
Head and Neck 54.0% 52.6% 55.0% 43.3% 59.9% 52.3%
Lower GI 67.5% 68.4% 67.8% 59.6% 71.3% 75.0%
Upper GI 36.9% 36.7% 38.7% 17.6% 37.9% 52.8%
HPB 32.1% 29.6% 34.0% 10.2% 32.2% 41.8%
Trachea, Bronchus & Lung 26.1% 22.8% 28.1% 13.1% 21.1% 28.8%
Melanoma of skin 96.7% 90.8% 97.2% 96.7% 97.9% 71.5%
Breast 76.4% 77.3% 76.4% 74.5% 79.0% 79.2%
Cervix 63.4% 58.8% 64.8% 53.6% 60.6% 56.1%
Other Female Genitals 75.8% 73.7% 76.7% 68.0% 76.6% 73.6%
Prostate 22.4% 16.8% 23.7% 13.9% 17.5% 12.0%
Kidney 59.8% 59.7% 60.7% 48.3% 59.6% 70.0%
Bladder 85.6% 85.2% 86.0% 79.9% 85.4% 89.6%
Brain and CNS 51.4% 50.3% 52.0% 47.6% 43.9% 57.7%
Thyroid & other endocrine glands 87.5% 84.2% 88.3% 80.5% 89.0% 78.9%
CUP 13.2% 11.6% 14.1% 4.7% 12.7% 14.8%
Other invasive cancer 56.7% 53.2% 58.1% 45.6% 53.0% 55.9%
Breast in situ 87.0% 87.7% 86.7% 91.8% 87.0% 85.4%
Cervix in situ 88.0% 70.4% 90.1% 98.3% 79.7% 13.5%
Other tumours 63.0% 60.4% 63.0% 71.1% 58.8% 48.8%
Non-Melanoma Skin Cancer 50.1% 55.5% 47.5% 91.5% 39.5% 43.6%

1 Data for Wales is on the preceding year.